Immuno Cytokines and Cell Markers Flashcards
IFN-α and IFN-β
Released by:
3 Effects:
Released by phagocytes in response to TLR-3 binding viral dsRNA
o Protects uninfected cells (inhibits translation of viral mRNA)
o Activates NK cells (kill virus infected cells)
o Increase expression of MHC class I (promote killing by Tc cells)
IFN-γ
Produced by:
4 Effects:
Involved in:
Inhibited by:
(Kong’s Tumor Immuno)
Produced by TH1 cells
o Activates macrophages and NK cells
o Upregulates MHC class II
o Induces B cells to produce IgG3 (complement)
o Inhibits formation of TH2 and TH17 cells
Involved in class switching
Inhibited by cyclosporine and tacrolimus
Produced by NK cells (Kong’s Tumor Immunity lecture)
IL-1
Released by:
Local and systemic effects:
PROINFLAMMATORY
Released by activated macrophages; released by dendritic cells in response to uptake of infectious agents
o Local: activates endothelium and lymphocytes
o Systemic: induces fever and stimulates IL-6 production
IL-2
Growth factor for:
Produced by:
Interaction of CD28 and B7 does what?
Effects of B7 interaction:
Production decreased by:
Inhibited by:
Growth factor for T cells (CD4, CD8) and NK cells
Produced by CD4+ cells (TH1) and SOME CD8+ cells
- Discrepancy between Kong and Sundick’s notes
- Sundick’s response: some CD8+ T cells produce IL-2 and therefore do not need CD4 to provide it
Interaction of CD28 (T cells) and B7 (APCs) stimulates T cell and its production of IL2
B7 interaction:
- Increases transcription of IL-2 mRNA
- Increases half-life of IL-2 mRNA
Production decreased by interaction of CTLA4 and B7
Inhibited by cyclosporine and tacrolimus
IL-3
Macrophage differentiation in the bone marrow (similar to GM-CSF)
IL-4
What stimulates synthesis?
Effects from TH2?
Involved in:
Gene clusters involved in:
Effects in Type I hypersensitivity
Inhibited by:
Parasitic worms and allergens stimulate synthesis of IL-4, promoting formation of TH2 cells
TH2 cells release IL-4
- Induces B cells to produce IgE and IgG4 (along with IL-13)
- Prevents development of TH1 and TH17 cells
Involved in class switching
IL4 gene cluster possibly involved in genetic component of allergy
Released as a preformed substance from mast cells during type I hypersensitivity
Inhibited by cyclosporine and tacrolimus
IL-5
Released by:
Growth factor for:
Released by TH2 cells
-Growth factor for eosinophils
Released as a preformed substance by mast cells during type I hypersensitivity
IL-6
Released by:
Local and systemic effects
PROINFLAMMATORY
Released by activated macrophages
- Local: activates lymphocytes and increases Ab production
- Systemic: induces fever; induces liver to produce acute phase proteins (CRP, MBL, SPA, SPB-opsonize bacteria, activate complement)
IL-7
Effects on T and B cells
Required for development of B cells from stem cells (along with stromal cells)
Required for development of T cells in the thymus (along with contact from dendritic and epithelial cells)
IL-8
Released by:
Released by activated macrophages
- Chemokine that attracts PMNs, basophils and T cells
Released as a preformed substance in mast cell granules during Type I hypersensitivity
- Chemokine that attracts PMNs
IL-10
Suppresses:
Released by:
Release of IL-10 + TGF-β by Treg cells suppresses the formation of TH1, TH2 and TH17 cells
Activated TH2 cells released TGF-β, IL-4 and IL-10 [discrepancy between Kong and Sundick]
IL-12
Released by:
Activates and induces:
(Kong’s lecture)
Released by activated macrophages; released by dendritic cells in response to uptake of infectious agents
- Activates NK cells (kill virus infected and tumor cells; cells that are deficient in MHC I)
- Induces CD4+ TH0 cells to become TH1 cells
Produced by NK cells (Kong’s Tumor Immunity lecture)
IL-13
Released by TH2 cells
o Induces B cells to produce IgE and IgG4 (along with IL-4)
IL-17+ IL-22
Released by TH17 cells
- Recruit and activate PMNs
- Induce epithelial cells to produce proinflammatory cytokines (IL1, IL6, TNFα)
IL-21
Release of IL-21 + TGF-β by dendritic cells leads to formation of TH17 cells
TGF-β
Dendritic cells release in combo:
Alone:
Treg release:
2 other cells release:
Release of IL-21 + TGF-β by dendritic cells leads to formation of TH17 cells
Release of TGF-β alone by dendritic cells leads to formation of Treg cells
Treg cells release TGF-β + IL-10 to suppress the formation of TH1, TH2, and TH17 cells
Activated TH2 cells released TGF-β, IL-4 and IL-10 [discrepancy between Kong and Sundick]
Can be secreted by tumor cells in tumor-induced immunosuppression (suppress T cell function)
TNF-α
Released by:
Local and systemic effects:
(Kong’s lecture)
PROINFLAMMATORY
Released by activated macrophages; released by dendritic cells in response to uptake of infectious agents
- Local: activates vascular endothelium by inducing adhesion molecules- selectins (E), ICAMs (E), integrins (L); induce permeability (promotes diapedesis)
- Systemic: fever and shock
Produced by NK cells (Kong’s Tumor Immunity lecture)
TNF-β (Lymphotoxin)
Promotes:
Released by:
Promotes diapedesis of fresh macrophages to site of infection
Released by activated TH1 cells in delayed-type hypersensitivity reaction against tissue grafts (cytotoxic to graft)
GM-CSF
Released as a preformed substance by mast cells during type I hypersensitivity
Macrophage differentiation in bone marrow
C5a
Chemotactic factor for PMNs; vasoactive; activate mast cells
C3a
Vasoactive; activate mast cells
C2b
Buildup causes swelling (as seen in C1 inhibitor deficiency- hereditary angioneurotic edema)
ECF
Eosinophilic chemotactic factor; preformed substance in mast cells
Thromboxanes/Prostaglandins
Chemotactic for PMNs and eosinophils
TCR Complex: 3 Parts (T Cells)
TCR: heterodimer Ag-specific receptor (first signal necessary to activate T cells)
CD3: pan T cell marker; signal transduction, transports TCR to cytoplasmic membrane; invariant
Zeta chains (2): signal transduction; invariant
CD2 (T Cells)
Pan T cell marker; lymphocyte adherence and signaling
Integrins (LFA-1 and VLA-4) (T Cells)
On T Cells
Adherence to APC and endothelial cell
CD62L/L-Selectin
On T Cells
Homing molecule that binds addressins on the endothelium; facilitates migration of T cell into LN
ICOS
On T Cells
Interacts with ICOSL on B cell; facilitates germinal center formation in LNs and other lymphoid tissue
CD4
On Th cells; stabilizes binding and involved in signaling
CD8
On Tc cells; stabilizes binding and involved in signaling
CD28 (T Cells)
Binds B7 on APC (required for activation of T cell)
CTLA4/CD154
Upregulated in activated T cells; interaction with B7 on APC shuts down T cell
Class I MHC
On all nucleated cells
FasL
On CD8+ T cells; allows for killing of Fas+ cells
CCL2 (MCP-1)
Allows for migration of TH1 cells to site of infection
BCR
Ig + Igα and Igβ (signal transduction molecules associated with the Ig H chain)
B-Cell Co-Receptor: 3 Parts
CD21: binds C3dg (cleavage product of C3b) on bacteria to increase Ag signaling 100x; also a receptor for the Epstein Barr Virus
CD19
CD81
CD22
Downregulate B cell activity
CD32
Downregulate B cell activity
Binds Ag-Ab Complexes
CD5
On surface of B-1 cells
B7
On B Cells
Interacts with CD28 (stimulation) or CTLA4 (inhibition) on T cells
FcR
Receptor for Fc portion of Igs (one for each class); delivers signal to B cell
Class I MHC
Location, Chains, Interactions, Peptide Binding Groove
On all nucleated cells
3 loci (A,B,C) encode alpha chain only
Alpha chain combines with invariant beta-2 microglobulin
Alpha3 domain interacts with CD8 on T cells
Alpha1 and 2 domains form CLOSED peptide binding groove (8-9 aa)
Class II MHC
Location, Chains, Interactions, Peptide Binding Groove
On APCs
3 loci (DP, DQ, DR) encode both alpha and beta chains
Beta2 domain interacts with CD4 on T cells
Alpha1 and Beta1 domains form OPEN peptide binding groove (12-20 aa)
Mannose-Binding Lectin Receptor
On Phagocyte
Binds MBL bound to mannose on bacterial surface (increases binding affinity)
Mannose Receptor
On Phagocyte
Binds mannose on surface of bacteria
Surfactant Protein A and D Receptors
On Phagocyte
Binds SPA/SPD bound to bacteria (increases binding affinity)
Scavenger Receptors
On Phagocyte
React with lipoprotein
fMet-Leu-Phe (N-formylated peptides) Receptor
On Phagocyte
Receptor for these peptides, which are chemotactic factors for phagocytes
Toll-Like Receptors (Phagocyte)
TLR-3,4,5,9
TLR-4
Binds bacterial LPS and triggers activation of NFkB (genes transcribed to fight bacteria)
TLR-3
Binds viral dsRNA triggering synthesis of IFN alpha and beta
TLR-5
Bacterial flagellin
TLR-9
Unmethylated CpG DNA
TLR1:TLR2 heterodimer
Peptidoglycan and zymosan
Integrins (Leukocytes)
Bind ICAMs on endothelium and APC (strong binding)
Hypersensitivity Type I
Systemic anaphylaxis
Allergic rhinitis
Asthma
Food allergies
Hypersensitivity Type II
ABO/Rh incompatability reaction
Myastenia gravis
Grave’s Disease
Penicillin drug allergy (can also be IgE mediated-type I)
Hypersensitivity Type III
Serum sickness
Arthus reaction
SLE
Rhematoid arthritis
Hypersensitivity Type IV
Posion ivy (contact dermatitis) Tuberculin rejection Graft rejection Hashimoto’s Thyroiditis Multiple Sclerosis IDDM
CD40
Interacts with CD40L on T cells to allow for Ab class switching